Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies

被引:0
|
作者
Yuki Kita
Akihiro Hamada
Ryoichi Saito
Yuki Teramoto
Ryusuke Tanaka
Keishi Takano
Kenji Nakayama
Kaoru Murakami
Keiyu Matsumoto
Shusuke Akamatsu
Toshinari Yamasaki
Takahiro Inoue
Yasuhiko Tabata
Yasushi Okuno
Osamu Ogawa
Takashi Kobayashi
机构
[1] Kyoto University Graduate School of Medicine,Department of Urology
[2] Kyoto University Graduate School of Medicine,Department of Diagnostic Pathology
[3] Kyoto University,Laboratory of Biomaterials, Department of Regeneration Science and Engineering, Institute for Frontier Life and Medical Sciences
[4] Hokkaido Institute of Public Health,Department of Environmental and Health Sciences
[5] Shimadzu Techno-research,Department of Clinical System Onco
[6] Kyoto University Graduate School of Medicine,Informatics
来源
British Journal of Cancer | 2019年 / 121卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1027 / 1038
页数:11
相关论文
共 2 条
  • [1] Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
    Kita, Yuki
    Hamada, Akihiro
    Saito, Ryoichi
    Teramoto, Yuki
    Tanaka, Ryusuke
    Takano, Keishi
    Nakayama, Kenji
    Murakami, Kaoru
    Matsumoto, Keiyu
    Akamatsu, Shusuke
    Yamasaki, Toshinari
    Inoue, Takahiro
    Tabata, Yasuhiko
    Okuno, Yasushi
    Ogawa, Osamu
    Kobayashi, Takashi
    BRITISH JOURNAL OF CANCER, 2019, 121 (12) : 1027 - 1038
  • [2] Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells
    Ketola, Kirsi
    Kallioniemi, Olli
    Iljin, Kristiina
    PLOS ONE, 2012, 7 (12):